Read our recent article “The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses- Immunomodulatory Drugs as an Approach to Therapy“, published in Frontiers in Pharmacology in May 2022. It reviews current knowledge about inflammation in patients affected by Mucopolysaccharidoses and provides hypotheses for the therapeutic use of immunomodulators in this group of diseases.
Citation: Wiesinger AM, Bigger B, Giugliani R, Scarpa M, Moser T, Lampe C, Kampmann C, Lagler FB. The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses – Immunomodulatory Drugs as an Approach to Therapy. Front Pharmacol. 2022 May 13. doi:10.3389/fphar.2022.863667.
Find other published articles authored by MetabERN members in the publications section.
